Filter posts

New CDC Report on Alarming Rates of Antibiotic-Resistant Infections

Every year in the United States, 2 million people acquire an antibiotic-resistant infection. Of those, at …

BIO Investor Forum Company Snapshot: Opsona Therapeutics

Opsona Therapeutics will be participating in the upcoming BIO Investor Forum, and will be giving …

BIO Investor Forum Company Snapshot: Vaccinex

Recently, the CEO of Prosensa provided their company’s perspective participating in last year’s BIO Investor Forum. …

12th Annual BIO Investor Forum Presenting Companies Announced

Looking to lose a few pounds? Don’t want to diet or exercise? You’re not alone: …

Prosensa's IPO and the Value of the BIO Investor Forum

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of …

JOBS Act Provides Innovators with Capital Boost

Despite all the talk of gridlock and polarization in Washington these days, successful, bipartisan pieces …

BIO Investor Forum Company Snapshot: NovelMed Therapeutics

NovelMed Therapeutics will be presenting at the upcoming BIO Investor Forum in October in San …

GAINing Ground in Antibiotics

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an …

BIO Investor Forum Company Snapshot: MAX BioPharma

Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event …

BIO Investor Forum Company Snapshot: AM-Pharma

The BIO Investor Forum will be taking place this October in San Francisco for its …